Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study.
Ma YY, Wei ZL, Xu YJ, Shi JM, Yi H, Lai YR, Jiang EL, Wang SB, Wu T, Gao L, Gao L, Kong PY, Wen Q, Bai H, Li Y, Cao YG, Li QC, Zhang ZM, Liu BC, Su Y, Lai XY, Ma X, Cheng TT, Luo Y, Zhang X, Zhang C. Ma YY, et al. Among authors: gao l. Cancer. 2023 Jul 1;129(13):2013-2022. doi: 10.1002/cncr.34762. Epub 2023 Mar 23. Cancer. 2023. PMID: 36951498
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme.
Wang L, Kong P, Zhang C, Gao L, Zhu L, Liu J, Gao S, Chen T, Liu H, Yao H, Liu Y, Feng Y, Zhao L, Li Y, Gao L, Zhang X. Wang L, et al. Among authors: gao s, gao l. Ann Hematol. 2023 Jun;102(6):1569-1579. doi: 10.1007/s00277-023-05220-7. Epub 2023 Apr 25. Ann Hematol. 2023. PMID: 37097455 Free PMC article.
Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia.
Xiang X, Li F, Zhou S, Zeng Y, Deng X, Zhang H, Li J, Liu H, Rao J, Gao L, Zhang C, Wen Q, Gao L, Zhang X. Xiang X, et al. Among authors: gao l. PPAR Res. 2023 Jun 26;2023:8456833. doi: 10.1155/2023/8456833. eCollection 2023. PPAR Res. 2023. PMID: 37404899 Free PMC article.
Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia.
Feng Y, Chen T, Zhang Y, Yao H, Wang P, Wang L, Cassady K, Zou Z, Liu Y, Zhao L, Gao L, Zhang X, Kong P. Feng Y, et al. Among authors: gao l. Front Immunol. 2023 Jun 22;14:1182251. doi: 10.3389/fimmu.2023.1182251. eCollection 2023. Front Immunol. 2023. PMID: 37435080 Free PMC article.
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.
Huang R, Chen T, Wang S, Wang J, Su Y, Liu J, Zhang Y, Ma X, Wen Q, Kong P, Zhang C, Gao L, Zhong JF, Gao L, Zhang X. Huang R, et al. Among authors: gao l. JAMA Oncol. 2024 Feb 1;10(2):220-226. doi: 10.1001/jamaoncol.2023.5757. JAMA Oncol. 2024. PMID: 38153755 Free PMC article. Clinical Trial.
Efficiency and Toxicity of Imatinib Mesylate combined with Atorvastatin Calcium in the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease: A Single-center, Prospective, Single-arm, Open-label study.
Chen T, Li J, Wei X, Yao H, Zhu L, Liu J, Liu Y, Wang P, Feng Y, Gao S, Liu H, Wang L, Zhao L, Gao L, Zhang C, Gao L, Zhang X, Kong P. Chen T, et al. Among authors: gao s, gao l. Acta Haematol. 2024 Jan 17. doi: 10.1159/000536174. Online ahead of print. Acta Haematol. 2024. PMID: 38232716
16,238 results
You have reached the last available page of results. Please see the User Guide for more information.